Biocon
-
Biocon Biologics facility gets EU GMP certification for Bevacizumab
Business | April 28, 2023 18:46 ISTBiocon Biologics' facility has received a certificate of GMP compliance for Bevacizumab from the representative European inspection authority -- Health Products Regulatory Authority (HPRA), Ireland.
-
Biocon Biologics to offer 15% stake to Serum Institute Life Sciences at valuation of USD 4.9 bn
Business | September 16, 2021 23:02 ISTBiocon Biologics, a subsidiary of Biocon, on Thursday said it will offer around 15 per cent stake to Serum Institute Life Sciences at a post-money valuation of about USD 4.9 billion. Serum Institute Life Sciences (SILS) is a subsidiary of Serum Institute of India (SII).
-
Jeetega India | 'Ramping up vaccine production is complex': Kiran Mazumdar Shaw, Chairperson Biocon
News | May 09, 2021 14:40 ISTExecutive Chairperson, Biocon Kiran Mazumdar Shaw spoke at the India TV Conclave. She talked about the hurdles in ramping up vaccination. Apart from this, she said, "People who haven't ever tested positive for COVID 19 should be prioritized for vaccination, as they're more susceptible to it".
-
Biocon Q3 net profit falls 19 per cent to Rs 186.6 cr
Business | January 22, 2021 11:38 ISTExecutive Chairperson Kiran Mazumdar-Shaw said the consolidated revenue for Q3 FY21 was driven by 13 per cent growth in research services and 11 per cent in biosimilar business segments.
-
DGCI approved Biocon drug to be used for treatment of moderate to severe COVID-19 patients
Health | July 13, 2020 18:26 ISTThe executive chairperson of Biocon, Kiran Mazumdar Shaw said, "It is an injection containing 25mg/5mL solution for emergency use in India for the treatment of Cytokine Release distress syndrome (ADRS) patients caused by the COVID-19".
-
Biocon's Itolizumab approved as life-saving COVID-19 medicine; Kiran Mazumdar-Shaw announces details
India | July 13, 2020 15:17 ISTKiran Mazumdar Shaw, the Executive Chairperson of Biocon Limited, announced Monday that it has received the Drugs Controller General of India’s (DCGI) approval to market Itolizumab (ALZUMAb) Injection 25mg/5mL solution for emergency use in India for the treatment of cytokine release syndrome (CRS) in moderate to severe ARDS (acute respiratory distress syndrome) patients due to COVID-19.
-
Biocon drug receives DCGI nod for use in moderate to severe COVID-19 patients
Business | July 11, 2020 17:22 ISTBiotechnology major Biocon on Saturday announced that its "breakthrough drug," Itolizumab has received Drugs Controller General of India's (DCGI) approval for its use in moderate to severe COVID-19 patients.
-
USFDA accepts proposed biosimilar application by Mylan, Biocon for review
Business | March 09, 2020 12:51 ISTThe US Food and Drug Administration (USFDA) has accepted biologics license application by Mylan and Biocon for proposed biosimilar to Bevacizumab for review, according to a regulatory filing.
-
Indian Biotechnology major Biocon to make 3 generic drugs in China
Business | September 14, 2019 22:49 ISTBiotechnology major Biocon would make three generic drugs for hard-selling in China through partnership, the company said on Saturday.
-
I don't give much thought to rich list: Biocon's Kiran Mazumdar-Shaw
Business | October 06, 2017 16:13 ISTBiotechnology pioneer Kiran Mazumdar-Shaw says the latest list of 100 rich persons in India reflects the state of the economy.
-
Shah Rukh Khan finds his role model in this Indian woman and no, she's not from Bollywood!
Bollywood | April 01, 2017 18:23 ISTShah Rukh reveals where he draws his inspiration for success from. The Bollywood superstar considers Kiran Mazumdar Shaw, the chairperson of leading Indian biotech company, Biocon, his role model.
-
Biocon Q3 net dips 13% to Rs 91 crore; to offload 10-15% in Syngene
January 23, 2015 17:11 ISTNew Delhi: Biotech firm Biocon reported a 13 percent dip in net profit for October-December quarter at Rs 91 crore and said it will sell 10-15 percent stake in its research services arm Syngene.The company
-
'Biocon planning to set up manufacturing unit in Vizag'
December 15, 2014 11:10 ISTHyderabad: Pharmaceutical giant Biocon is contemplating setting up a manufacturing facility in Visakhapatnam, Andhra Pradesh government said Sunday."Biocon Chairperson and Managing Director (CMD) Kiran Mazumdar Shaw met Chief Minister N Chandrababu Naidu at his residence
-
Biocon Q2 net flat at Rs 102 crore
October 22, 2014 17:14 ISTNew Delhi: Biotechnology major Biocon today reported a flat growth in its consolidated net profit at Rs 102.05 crore for the quarter ended September 30, 2014.The company had posted a net profit after tax and
-
Global Economy Prize for India's biotech queen
June 24, 2014 7:35 ISTBangalore: India's biotechnology queen and Biocon chairperson Kiran Mazumdar-Shaw has been awarded the coveted Global Economy Prize for business by the Kiel Institute in Germany during its centenary celebrations."Mazumdar-Shaw is the first Indian woman and
-
Biocon Q4 net dips 54% at Rs 113 crore
April 26, 2014 17:17 ISTNew Delhi: Biotechnology major Biocon today reported a 54.51% decline in its consolidated net profit at Rs 113.08 crore for the fourth quarter ended March 31, 2014. The company had posted a net profit of
-
Biocon Q1 net rises 19% to Rs 93.5 cr
July 26, 2013 11:58 ISTNew Delhi, July 26: Biocon has reported a 18.65 per cent rise in consolidated net profit at Rs 93.50 for the first quarter ended June 30, 2013 mainly on account of strong performance in the
-
Biocon group net up 51% in fiscal 2013
April 28, 2013 15:09 ISTBangalore, April 28: India's biotechnology major Biocon Ltd posted consolidated net profit of Rs.509 crore for fiscal 2012-13, registering a whopping 51 percent year-on-year (YoY) growth over previous fiscal (2011-12) at Rs.338 crore.In a regulatory
-
Biocon Q3 net up 9% at Rs. 93 cr
January 25, 2013 13:01 ISTNew Delhi, Jan 25: Biotechnology major Biocon on Friday posted a 9.38% increase in its consolidated net profit at Rs. 92.81 crore for the third quarter ended December 31, 2012.The company had posted a net
-
Kiran Mazumdar-Shaw joins United States Pharmacopeial Convention board
January 25, 2013 11:48 ISTPune, Jan 24: Kiran Mazumdar-Shaw, CMD of Biocon, has been chosen to be on its board on trustees by The United States Pharmacopeial Convention (USP), a non-profit, standards setting organisation that advances public health through
Top News
-
Sunita Williams, Butch Willmore return LIVE updates: NASA says 'they are on their way'
-
Curfew imposed, several injured: How Aurangzeb tomb row led to violent clashes in Nagpur | Explained
-
ED summons Lalu Prasad Yadav for questioning in land-for-jobs case tomorrow
-
Marvel star Jonathan Majors admits to strangling ex-girlfriend, audio surfaces
Latest News
-
Google’s Find My Device app gets a major upgrade: People tracking now live!
-
China conducts massive drills near Taiwan, blames statements from US, Taiwanese leaders for move
-
Shaheen Afridi equals Pakistan's unwanted bowling record during 2nd T20I against New Zealand
-
New Zealand hammer Pakistan again in rain-hit second T20I, take 2-0 lead in series
-
Aamir Khan to Deepika Padukone, Bollywood actors and their infamous phobias
Trending
-
Bengaluru's MG Road photo from 1950 goes viral, netizens say 'must have been a paradise'
-
German woman dancing to 'Soni Soni' wins hearts, netizen calls her 'Bollywood-ready'
-
MS Dhoni, Suresh Raina set dance floor on fire at Rishabh Pant's sister's wedding ceremony | WATCH
-
Pack of stray dogs attack 18-year-old girl in Rajasthan's Alwar | WATCH
-
'Mom-E ride!': Internet reacts as mother uses chair to give daughter a roller coaster ride | WATCH